PK of FG-4592
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function (NCT02161224) | Astellas Pharma Europe B.V. | 2013-09-01 |
Track PK of FG-4592 automatically
Every clearance here is in the API, with alerts when new ones post.